MedPath

Theory Based Intervention Program to Support Physical Activity for Individuals With Multiple Sclerosis: a Case Series

Not Applicable
Completed
Conditions
Multiple Sclerosis
Registration Number
NCT02335450
Lead Sponsor
Oakland University
Brief Summary

This study evaluates the effectiveness of personalized physical activity coaching combined with the use of a physical activity monitor to support increased levels of daily physical activity in individuals with multiple sclerosis. All five participants will receive the intervention over the four week intervention phase.

Detailed Description

Individuals with multiple sclerosis engage in less daily physical activity than the general population for a variety of reasons. This research project is intended to evaluate whether individualized coaching combined with the use of a Fitbit physical activity wristband monitor will improve physical activity levels in individuals with multiple sclerosis.

Following admission into the study, participants will be visited once a week for four weeks at home by a physical therapist. The participants in consultation with the physical therapist will set daily physical activity goals for the following week and the participants will be taught how to monitor their daily activity using a Fitbit physical activity wristband.

The goals of this study are to determine whether this intervention is effective in helping participants increase their levels of daily physical activity and their confidence that they can successfully engage in daily physical activity. In addition, there will be an evaluation of changes from pre-intervention to post-intervention in quality of life measures.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • must have a physician diagnosis of multiple sclerosis and deemed suitable for engaging in a physical activity program by their physician
  • must be ambulatory with or without an assistive device
  • must be able to speak and read English
  • must have a home computer or device capable of tracking and recording the daily Fitbit physical activity reports
Exclusion Criteria
  • participants will be excluded if any contraindications to engaging in independent exercise are identified during the intake examination by the physical therapist: cardiovascular issues or safety issues with walking.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Total Steps Taken Over Course of the Study4 weeks

Wristband physical activity monitor recorded steps taken by participant over the 4 weeks of the study. No minimum or maximum. No baseline taken so cannot compare pre-intervention to post intervention.

Secondary Outcome Measures
NameTimeMethod
Exercise Self-Efficacy Questionnairebaseline and at end of 4-week intervention

The "Exercise Self-Efficacy Scale" is the participant's self-reported confidence in their ability to engage in exercise throughout the day. Each of the 6 items is scored from 0% confidence to 100% confidence. All items are summed and the score is divided by 6 Minimum score: 0 Maximum score:100 Higher scores mean a better outcome.

Multiple Sclerosis Impact Scalebaseline compared to end of 4-week study

The "Multiple Sclerosis Impact Scale" is a self-report on how multiple sclerosis has impacted day-to-day life during the past 2 weeks. The 29 items are graded by the participants on a 5 point scale rating from "not at all" to "extremely".

Minimum score: 29 Maximum Score:145 Higher scores mean worse outcome.

Multiple Sclerosis Self-Efficacy Scalebaseline compared to end of 4-week study

The "Multiple Sclerosis Self-Efficacy Scale" is a self-report of impact of multiple sclerosis on quality of life. The 14 statements are answered by selecting one of six options from strongly disagree to strongly agree.

Minimum value: 14 Maximum value: 84 Higher scores reflect mean a better outcome.

Trial Locations

Locations (1)

Oakland University

🇺🇸

Rochester, Michigan, United States

Oakland University
🇺🇸Rochester, Michigan, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.